167 related articles for article (PubMed ID: 19552757)
1. Overexpression of AIB1 predicts resistance to chemoradiotherapy and poor prognosis in patients with primary esophageal squamous cell carcinoma.
He LR; Liu MZ; Li BK; Rao HL; Deng HX; Guan XY; Zeng YX; Xie D
Cancer Sci; 2009 Sep; 100(9):1591-6. PubMed ID: 19552757
[TBL] [Abstract][Full Text] [Related]
2. Nrf2 is useful for predicting the effect of chemoradiation therapy on esophageal squamous cell carcinoma.
Kawasaki Y; Okumura H; Uchikado Y; Kita Y; Sasaki K; Owaki T; Ishigami S; Natsugoe S
Ann Surg Oncol; 2014 Jul; 21(7):2347-52. PubMed ID: 24599410
[TBL] [Abstract][Full Text] [Related]
3. COX2 expression predicts resistance to chemoradiotherapy in esophageal squamous cell carcinoma.
Akutsu Y; Hanari N; Yusup G; Komatsu-Akimoto A; Ikeda N; Mori M; Yoneyama Y; Endo S; Miyazawa Y; Matsubara H
Ann Surg Oncol; 2011 Oct; 18(10):2946-51. PubMed ID: 21437756
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiation therapy.
Okumura H; Uchikado Y; Matsumoto M; Owaki T; Kita Y; Omoto I; Sasaki K; Sakurai T; Setoyama T; Nabeki B; Matsushita D; Ishigami S; Hiraki Y; Nakajo M; Natsugoe S
Int J Clin Oncol; 2013 Apr; 18(2):329-34. PubMed ID: 22350023
[TBL] [Abstract][Full Text] [Related]
5. High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.
He LR; Liu MZ; Li BK; Jia WH; Zhang Y; Liao YJ; Chen YC; Zhang LJ; Guan XY; Zeng YX; Kung HF; Xie D
Int J Cancer; 2010 Jul; 127(1):138-47. PubMed ID: 19904743
[TBL] [Abstract][Full Text] [Related]
6. Phase II feasibility study of preoperative concurrent chemoradiotherapy with cisplatin plus 5-fluorouracil and elective lymph node irradiation for clinical stage II/III esophageal squamous cell carcinoma.
Hashimoto J; Kato K; Ito Y; Kojima T; Akimoto T; Daiko H; Hamamoto Y; Matsushita H; Katano S; Hara H; Tanaka Y; Saito Y; Nagashima K; Igaki H
Int J Clin Oncol; 2019 Jan; 24(1):60-67. PubMed ID: 30109544
[TBL] [Abstract][Full Text] [Related]
7. The telomere/telomerase binding factor PinX1 is a new target to improve the radiotherapy effect of oesophageal squamous cell carcinomas.
Qian D; Zhang B; He LR; Cai MY; Mai SJ; Liao YJ; Liu YH; Lin MC; Bian XW; Zeng YX; Huang JJ; Kung HF; Xie D
J Pathol; 2013 Apr; 229(5):765-74. PubMed ID: 23341363
[TBL] [Abstract][Full Text] [Related]
8. PITX2: a promising predictive biomarker of patients' prognosis and chemoradioresistance in esophageal squamous cell carcinoma.
Zhang JX; Tong ZT; Yang L; Wang F; Chai HP; Zhang F; Xie MR; Zhang AL; Wu LM; Hong H; Yin L; Wang H; Wang HY; Zhao Y
Int J Cancer; 2013 Jun; 132(11):2567-77. PubMed ID: 23132660
[TBL] [Abstract][Full Text] [Related]
9. REG1A expression status suggests chemosensitivity among advanced thoracic esophageal squamous cell carcinoma patients treated with esophagectomy followed by adjuvant chemotherapy.
Sato Y; Motoyama S; Nanjo H; Ito S; Yoshino K; Sasaki T; Kuribayashi K; Nagaki Y; Imai K; Saito H; Minamiya Y; Ogawa J
Ann Surg Oncol; 2013 Sep; 20(9):3044-51. PubMed ID: 23645481
[TBL] [Abstract][Full Text] [Related]
10. Predictors of sensitivity to chemoradiotherapy of esophageal squamous cell carcinoma.
Yi Y; Li B; Sun H; Zhang Z; Gong H; Li H; Huang W; Wang Z
Tumour Biol; 2010 Aug; 31(4):333-40. PubMed ID: 20490963
[TBL] [Abstract][Full Text] [Related]
11. Comparison between radical esophagectomy and definitive chemoradiotherapy in patients with clinical T1bN0M0 esophageal cancer.
Motoori M; Yano M; Ishihara R; Yamamoto S; Kawaguchi Y; Tanaka K; Kishi K; Miyashiro I; Fujiwara Y; Shingai T; Noura S; Ohue M; Ohigashi H; Nakamura S; Ishikawa O
Ann Surg Oncol; 2012 Jul; 19(7):2135-41. PubMed ID: 22302264
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemoradiotherapy followed by esophagectomy for initially resectable squamous cell carcinoma of the esophagus with multiple lymph node metastasis.
Nabeya Y; Ochiai T; Matsubara H; Okazumi S; Shiratori T; Shuto K; Aoki T; Miyazaki S; Gunji Y; Uno T; Ito H; Shimada H
Dis Esophagus; 2005; 18(6):388-97. PubMed ID: 16336610
[TBL] [Abstract][Full Text] [Related]
13. The usefulness of neoadjuvant chemoradiation therapy for locally advanced esophageal cancer with multiple lymph-node metastases.
Okumura H; Uchikado Y; Omoto I; Kita Y; Sasaki K; Arigami T; Uenosono Y; Matsushita D; Hiraki Y; Owaki T; Ishigami S; Natsugoe S
Ann Surg Oncol; 2014 Sep; 21(9):2845-9. PubMed ID: 24728820
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of H3K27me3 expression on locoregional progression after chemoradiotherapy in esophageal squamous cell carcinoma.
He LR; Liu MZ; Li BK; Rao HL; Liao YJ; Guan XY; Zeng YX; Xie D
BMC Cancer; 2009 Dec; 9():461. PubMed ID: 20028503
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant concurrent chemoradiotherapy followed by definitive high-dose radiotherapy or surgery for operable thoracic esophageal carcinoma.
Murakami M; Kuroda Y; Okamoto Y; Kono K; Yoden E; Kusumi F; Hajiro K; Matsusue S; Takeda H
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1049-59. PubMed ID: 9539559
[TBL] [Abstract][Full Text] [Related]
16. TENERGY: multicenter phase II study of Atezolizumab monotherapy following definitive Chemoradiotherapy with 5-FU plus Cisplatin in patients with unresectable locally advanced esophageal squamous cell carcinoma.
Bando H; Kotani D; Tsushima T; Hara H; Kadowaki S; Kato K; Chin K; Yamaguchi K; Kageyama SI; Hojo H; Nakamura M; Tachibana H; Wakabayashi M; Fukutani M; Togashi Y; Fuse N; Nishikawa H; Kojima T
BMC Cancer; 2020 Apr; 20(1):336. PubMed ID: 32312286
[TBL] [Abstract][Full Text] [Related]
17. Correlation between high FBXW7 expression in pretreatment biopsy specimens and good response to chemoradiation therapy in patients with locally advanced esophageal cancer: A retrospective study.
Gombodorj N; Yokobori T; Tanaka N; Suzuki S; Kuriyama K; Kumakura Y; Yoshida T; Sakai M; Sohda M; Baatar S; Miyazaki T; Nishiyama M; Shirabe K; Kuwano H
J Surg Oncol; 2018 Jul; 118(1):101-108. PubMed ID: 30098297
[TBL] [Abstract][Full Text] [Related]
18. Utility of weekly docetaxel combined with preoperative radiotherapy for locally advanced esophageal cancer from pathological analysis.
Kushida T; Nohara S; Yoshino K; Fujiwara D; Ouchi K; Amano T; Isayama F; Tomita N; Iwanuma Y; Sasai K; Tsurumaru M; Kajiyama Y
Dis Esophagus; 2014; 27(4):368-73. PubMed ID: 23865505
[TBL] [Abstract][Full Text] [Related]
19. Association of decreased expression of long non-coding RNA LOC285194 with chemoradiotherapy resistance and poor prognosis in esophageal squamous cell carcinoma.
Tong YS; Zhou XL; Wang XW; Wu QQ; Yang TX; Lv J; Yang JS; Zhu B; Cao XF
J Transl Med; 2014 Aug; 12():233. PubMed ID: 25169763
[TBL] [Abstract][Full Text] [Related]
20. Cervical nodal metastases of unresectable thoracic esophageal squamous cell carcinoma: characteristics of long-term survivors after concurrent chemoradiotherapy.
Liu H; Lu L; Zhu Q; Hao Y; Mo Y; Liu M; Hu Y; Cui N; Rong T
Radiother Oncol; 2011 May; 99(2):181-6. PubMed ID: 21620504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
